Connect your AI

Orthofix Medical Inc. OFIX Restricted Cash

Restricted Cash at other companies

OrthoPediatricsKIDS

$2.05M+3.1%

Carlsmed, Inc. Common StockCARL

$100K—

ClearPoint NeuroCLPT

$923K—

Boston ScientificBSX

——

Other financials

Income statement

Revenue$196.7M+1.6%

Gross profit$139.5M+14.7%

Operating income-$14.4M+70.5%

Net income-$20.9M+60.6%

EPS (diluted)-$0.52+61.5%

Balance sheet

Cash & equivalents$120.3M+108%

Total debt$237.5M+32.3%

Total equity$435.2M-5.0%

Total assets$886.6M+7.7%

Cash flow

Operating cash flow-$17.6M+4.2%

CapEx$10.7M+58.3%

Free cash flow-$28.3M-12.5%

Valuation

Market cap$376.33M-7.1%

Enterprise value$493.54M-6.3%

P/S0.5×0.0×

Profitability

Gross margin70.7%+3.6pp

Operating margin-5.8%-2.1pp

Net margin-7.3%-2.7pp

FCF margin-9.3%-1.7pp

Returns & leverage

Return on equity-13.4%-4.6pp

Debt / equity0.5×+0.2×

Current ratio2.9×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The official record: Orthofix Medical Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Orthofix Medical Inc.'s restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Orthofix Medical Inc.'s restricted cash?: Orthofix Medical Inc. (OFIX) reported restricted cash of $592K in Q1 2026.
How has Orthofix Medical Inc.'s restricted cash changed year-over-year?: Orthofix Medical Inc.'s restricted cash decreased by 76.3% year-over-year, from $2.5M to $592K.
What is the long-term trend for Orthofix Medical Inc.'s restricted cash?: Over 3 years (2020 to 2025), Orthofix Medical Inc.'s restricted cash has grown at a 80.0% compound annual growth rate (CAGR), from $530K to $3.09M.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.